167
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment

ORCID Icon, , , , , ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1474-1478 | Received 22 Oct 2021, Accepted 14 Jan 2022, Published online: 01 Feb 2022
 

Author contributions

SB, SM, EM and SH designed the research study, performed research, analyzed data and wrote paper, MPB, IP and FDM performed serological tests, FF performed flow cytometric analysis, EA, MV and FD collected clinical data, VDS and MS performed critical revision of the article. All authors approved the final manuscript.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

SH acknowledges research funding by a grant from the Italian Ministry of Education, Universities and Research (MIUR): PRIN Prot. 2017 PPS2X4.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.